Skip to content
IP + Technology Law
Home  »  News & Insights  »  News  »  Media Mention

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

News
Aug 2026
Knobbe Martens Partners Named Among Global IP Leaders in IAM Strategy 300 Guide
IRVINE, Calif., August 14, 2026 – Knobbe Martens is proud to share that eight of the firm’s partners were recognized in the 2026 edition of IAM Strategy 300: The World’s...
Publications
Aug 2026
What the ITC’s Zync v. BMW Decision Means for Section 337 Litigants
Key Takeaway: In a recent decision with implications for parties involved in intellectual property disputes before the International Trade Commission, an Administrative Law Judge terminated an ITC investigation based on...
News
Aug 2026
Nine Knobbe Martens Partners Recognized in 2026 Lexology Index: IP Guide
IRVINE, Calif., August 12, 2026 – Leading intellectual property law firm Knobbe Martens is pleased to share that nine partners have been recognized in the 2026 edition of Lexology Index:...